Vinay Prusty.

Vinay Prusty, MD, is the Executive Director of Neuroscience at Eli Lilly and Company, where they lead innovation in the rapidly evolving biological sciences landscape. Previously, Vinay served as the Clinical, Medical & Regulatory Director at Novo Nordisk, contributing to significant advancements in obesity and clinical trials. With extensive leadership experience in clinical, medical, regulatory, and quality roles, Vinay is committed to uncovering groundbreaking treatments for complex brain and cognitive health challenges. They hold an MBBS and an MD, along with additional education in clinical research and diabetes and metabolism.